ELEVATE Clinical Study

About DxTerity

DxTerity is a private, commercial-stage diagnostics company leveraging RNA expression profiling to advance precision medicine in autoimmune diseases. Its core technology, the Modular Immune Profile (MIP), analyzes immune-related gene expression from a simple at-home blood sample to monitor disease activity and treatment response. The company has validated its platform through multiple clinical studies (LIFT, EMPOWER, ELEVATE) and collaborates with research institutions and pharma partners. DxTerity operates on a diagnostics business model, generating early revenue from test kits and research services while aiming to secure broader insurance reimbursement.

Therapeutic Areas

Other Systemic Lupus Erythematosus Drugs